Teva Pharmaceutical Industries (NYSE:TEVA) shareholders are up 5.9% this past week, but still in the red over the last five years - Simply Wall St News
Teva Pharm expects to start paying U.S. opioid settlement in 2023 By Reuters
With 61% ownership of the shares, Teva Pharmaceutical Industries Limited ( NYSE:TEVA) is heavily dominated by institutional owners
Teva Stock Plunges On Flat Sales, Earnings Disappointment | Investor's Business Daily
Bullish Sentiment Surrounds Teva Pharmaceutical Industries with Large Options Position Taken - Best Stocks